Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients

This study has been completed.

Study NCT00426712 Information provided by Dynavax Technologies Corporation

First Received: January 23, 2007 Last Updated: July 20, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2008
Primary Completion Date:	March 2008 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: July 20, 2010